Bakkt Holdings
BKKT
Mawson Infrastructure
MIGI
BIT Mining
BTCM
Riot Platforms
RIOT
The9 Ltd
NCTY
US Stock MarketDetailed Quotes
NGNE Neurogene
- 14.210
- -1.020-6.70%
Close Mar 21 16:00 ET
- 14.320
- +0.110+0.77%
Post 20:01 ET
211.09MMarket Cap-5.02P/E (TTM)
15.230High13.805Low425.54KVolume15.050Open15.230Pre Close6.08MTurnover7.90%Turnover RatioLossP/E (Static)14.85MShares74.49052wk High1.54P/B76.51MFloat Cap13.80552wk Low--Dividend TTM5.38MShs Float1115.000Historical High--Div YieldTTM9.36%Amplitude7.500Historical Low14.281Avg Price1Lot Size
Market Insights
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
Neurogene Stock Forum
This Will continue to drive downward. And after you finally sell your position for a loss, they will buy back. Follow the money
📊⚡️📊
NEWS
Neurogene Announces Upcoming Presentation of Safety Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome at ASGCT Meeting
NEW YORK--(BUSINESS WIRE)-- Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that initial safety and tolerability data from its ongoing Phase 1/2 gene therapy clinical trial for Rett syndrome will be ...
No comment yet